Journal of translational medicine

publication venue for

Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study. 2016
Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors.. 21. 2023
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.. 21. 2023
M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma.. 21. 2023
DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome.. 20. 2022
Assessing the genetic burden of familial hypercholesterolemia in a large middle eastern biobank.. 20. 2022
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.. 20. 2022
Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes.. 20. 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.. 20. 2022
Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model.. 19. 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).. 19. 2021
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).. 19. 2021
Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery.. 18. 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).. 18. 2020
Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women.. 18. 2020
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated.. 18. 2020
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.. 18. 2020
Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.. 17. 2019
Akt-activated endothelium promotes ovarian cancer proliferation through notch activation.. 17. 2019
Correction to: Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.. 16. 2018
Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria.. 16. 2018
Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.. 16. 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.. 16. 2018
Prostate cancer small non-coding RNA transcriptome in Arabs.. 15. 2017
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.. 15. 2017
E-cadherin genetic variants predict survival outcome in breast cancer patients.. 14. 2016
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.. 14. 2016
Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay.. 14. 2016
Metabolic signatures differentiate ovarian from colon cancer cell lines.. 13. 2015
The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.. 13. 2015
Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype.. 13. 2015
Obesity susceptibility loci in Qataris, a highly consanguineous Arabian population.. 13. 2015
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer.. 13. 2015
Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population.. 13. 2015
Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.. 13. 2015
Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).. 13. 2015
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.. 12. 2014
Molecular epidemiology and genotype distribution of Human Papillomavirus (HPV) among Arab women in the State of Qatar.. 12. 2014
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.. 12. 2014
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis.. 12. 2014
Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.. 12. 2014
Metabolomics of Ramadan fasting: an opportunity for the controlled study of physiological responses to food intake.. 12. 2014
Cohort profile: Greifswald approach to individualized medicine (GANI_MED).. 12. 2014
Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.. 12. 2014
Rat model of veno-arterial extracorporeal membrane oxygenation.. 12. 2014
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.. 12. 2014
Melanoma risk loci as determinants of melanoma recurrence and survival.. 11. 2013
Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis.. 11. 2013
Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.. 11. 2013
Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.. 11. 2013
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice.. 11. 2013
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.. 11. 2013
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.. 11. 2013
Serum microRNAs as biomarkers for recurrence in melanoma.. 10. 2012
Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis.. 10. 2012
Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles.. 10. 2012
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.. 9. 2011
The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.. 9. 2011
Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies.. 9. 2011
Copy number and gene expression differences between African American and Caucasian American prostate cancer.. 8. 2010
Increased shedding of HU177 correlates with worse prognosis in primary melanoma.. 8. 2010
Optical imaging of the peri-tumoral inflammatory response in breast cancer.. 7. 2009
Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.. 7. 2009
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells.. 6. 2008
Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System.. 6. 2008
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.. 6. 2008
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo.. 5. 2007
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.. 5. 2007
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.. 5. 2007
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.. 5. 2007
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.. 5. 2007
Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.. 5. 2007
Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model.. 4. 2006
Clinical significance of BRAF mutations in metastatic melanoma.. 2. 2004
Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10.. 2. 2004
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines.. 2. 2004
Nicotinamide drives T cell activation in the mammary tumor microenvironment. 2022
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy). 2019
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). 2018
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. 2017
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. 2016
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. 2015
Cell death and senescence.. 21. 2023
Immune radiobiology.. 19. 2021
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy.. 15. 2017
Defining the critical hurdles in cancer immunotherapy.. 9. 2011
Personalized medicine: a patient-centered paradigm.. 9. 2011
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.. 8. 2010
Immunogenic cell death in cancer: concept and therapeutic implications. 2023
Precision medicine in the era of artificial intelligence: implications in chronic disease management. 2020
Angiocrine endothelium: from physiology to cancer. 2020
Precision medicine in breast cancer: reality or utopia? 2017
Genetic testing and genomic analysis: a debate on ethical, social and legal issues in the Arab world with a focus on Qatar. 2015
Role of mesenchymal cells in the natural history of ovarian cancer: a review. 2014
Cancer classification using the Immunoscore: a worldwide task force. 2012
A road map to Translational Medicine in Qatar and a model for the world. 2012
Considerations in the development of circulating tumor cell technology for clinical use. 2012
An immunologic portrait of cancer. 2011
Medical education and research environment in Qatar: a new epoch for translational research in the Middle East. 2011

VIVO Weill Cornell Medical College

Journal of translational medicine Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

Electronic International Standard Serial Number (EISSN)